跳至主要内容
临床试验/NCT04107571
NCT04107571Unknown不适用

A Chinese Registry to Determine the Serumal Biomarkers for Prognosis of Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.

Beijing Institute of Heart, Lung and Blood Vessel Diseases1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
2,000
试验地点
1
主要终点
All-cause death and cardiac death

研究概览

简要总结

This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject undergoing coronary artery bypass grafting;
  • Age is more than 18 and less than 80 years old;
  • Male and non pregnancy female;
  • Subject who understands study requirements and agrees to sign an informed consent from prior to study procedures.

排除标准

  • Pregnancy female;
  • Participate in other clinical trial in the last 1 month.
  • Subject who doesn't agree to sign an informed consent from prior to study procedures.
  • Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.

结局指标

主要结局

All-cause death and cardiac death

时间窗: These data is collected during follow-up visit at in-hospital/1 year after discharge

次要结局

  • Major adverse cardiac events (MACE)(These data is collected during follow-up visit at in-hospital/1 year after discharge)

研究者

发起方
Beijing Institute of Heart, Lung and Blood Vessel Diseases
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验